Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial - Concepedia

Concepedia

Publication | Closed Access

Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): health status analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

202

Citations

30

References

2021

Year

John A. Spertus, Jennifer Fine, Perry Elliott, Carolyn Y. Ho, Iacopo Olivotto, Sara Saberi, Wanying Li, Chantal Dolan, Matthew Reaney, Amy J. Sehnert,

CardiomyopathyHealth Status AnalysisCardiovascular DiseaseCardiac CareMedicineAnesthesiologyMyocardial Infarction

References

	Year	Citations

Page 1